The latest episode of Lung Cancer Considered focuses on the data and clinical outcomes for patients who may go off immunotherapy after two years. This episode features a conversation between host Dr. Jack West and Dr. Matt Hellman, associate attending at Memorial Sloan Kettering Cancer Center.
